Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes

被引:47
作者
Carbonnelle, E
Sparatore, F
Canu-Boido, C
Salvagno, C
Baldani-Guerra, B
Terstappen, G
Zwart, R
Vijverberg, H
Clementi, F
Gotti, C
机构
[1] Univ Milan, Dept Med Pharmacol, Sect Cellular & Mol Pharmacol, CNR,Inst Neurosci, I-20129 Milan, Italy
[2] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20129 Milan, Italy
[3] Univ Genoa, Dept Pharmaceut Sci, Genoa, Italy
[4] Glaxo Smithkline Med Res Ctr, Syst Res, Verona, Italy
[5] Univ Utrecht, Toxicol Res Inst, NL-3508 TD Utrecht, Netherlands
关键词
cytisine; nicotinic receptor; neuronal; agonist; antagonist; partial agonist; binding; FLIPR; electrophysiology;
D O I
10.1016/S0014-2999(03)01817-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytisine very potently binds and activates the alpha3beta4 and alpha7 nicotinic subtypes, but only partially agonises the alpha4beta2 subtype. Although with a lower affinity than cytisine, new cytisine derivatives with different substituents on the basic nitrogen (CC1-CC8) bind to both the heteromeric and homomeric subtypes, with higher affinity for brain [H-3]epibatidine receptors. The cytisine derivatives were tested on the Ca2+ flux of native or transfected cell lines expressing the rat alpha7, or human alpha3beta4 or alpha4beta2 subtypes using Ca2+ dynamics in conjunction with a fluorescent image plate reader. None elicited any response at doses of up to 30-100 muM, but all inhibited agonist-induced responses. Compounds CC5 and CC7 were also electrophysiologically tested on oocyte-expressed rat alpha4beta2, alpha3beta4 and alpha7 subtypes. CC5 competitively antagonised the alpha4beta2 and alpha3beta4 subtypes with similar potency, whereas CC7 only partially agonised them with maximum responses of respectively 3% and 11% of those of 1 mM acetylcholine. Neither compound induced any current in the oocyte-expressed alpha7 subtype, and both weakly inhibited acetylcholine-induced currents. Adding chemical groups of a different class or size to the basic nitrogen of cytisine leads to compounds that lose full agonist activity on the alpha3beta4 and alpha7 subtypes. (C) 2003 Elsevier Science B.V All rights reserved.
引用
收藏
页码:85 / 96
页数:12
相关论文
共 51 条
  • [1] AGONIST PHARMACOLOGY OF THE NEURONAL ALPHA-7 NICOTINIC RECEPTOR EXPRESSED IN XENOPUS-OOCYTES
    AMAR, M
    THOMAS, P
    JOHNSON, C
    LUNT, GG
    WONNACOTT, S
    [J]. FEBS LETTERS, 1993, 327 (03) : 284 - 288
  • [2] [Anonymous], 2000, HANDB EXP PHARM
  • [3] Antibodies against neuronal nicotinic receptor subtypes in neurological disorders
    Balestra, B
    Moretti, M
    Longhi, R
    Mantegazza, R
    Clementi, F
    Gotti, C
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (01) : 89 - 97
  • [4] SOME STUDIES ON CYTISINE AND ITS METHYLATED DERIVATIVES
    BARLOW, RB
    MCLEOD, LJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1969, 35 (01) : 161 - &
  • [5] Synthesis and preliminary pharmacological evaluation of some cytisine derivatives
    Boido, CC
    Sparatore, F
    [J]. FARMACO, 1999, 54 (07): : 438 - 451
  • [6] Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice
    Champtiaux, N
    Han, ZY
    Bessis, A
    Rossi, FM
    Zoli, M
    Marubio, L
    McIntosh, JM
    Changeux, JP
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (04) : 1208 - 1217
  • [7] Allosteric receptors after 30 years
    Changeux, JP
    Edelstein, SJ
    [J]. NEURON, 1998, 21 (05) : 959 - 980
  • [8] ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346
  • [9] Release of [H-3]-noradrenaline from rat hippocampal synaptosomes by nicotine: Mediation by different nicotinicreceptor subtypes from striatal [H-3]-dopamine release
    Clarke, PBS
    Reuben, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (04) : 595 - 606
  • [10] Neuronal nicotinic receptors, important new players in brain function
    Clementi, F
    Fornasari, D
    Gotti, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) : 3 - 10